Valuation Bio-Rad Laboratories, Inc.

Stocks

Real-time Estimate Cboe BZX 05:24:16 11/09/26 am AEST			5-day change	1st Jan Change
370.75 ^USD	-1.65%		-4.36%	+22.44%

10/09	Bio-Rad Laboratories, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 03:45 PM
07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,439	12,460	9,399	9,182	8,212	10,019	-	-
Change	-	-44.47%	-24.57%	-2.31%	-10.57%	22.01%	-	-
Enterprise Value (EV) ¹	22,439	11,868	8,992	8,730	7,874	9,270	9,054	8,913
Change	-	-47.11%	-24.24%	-2.91%	-9.8%	17.73%	-2.33%	-1.56%
P/E	5.38x	-	-14.8x	-5.03x	10.9x	45.3x	44.3x	44.6x
PBR	-	1.27x	1.05x	1.41x	1.11x	-	-	-
PEG	-	-	-	-0x	-0x	-0.6x	19.4x	-63.26x
Capitalization / Revenue	7.68x	4.45x	3.52x	3.58x	3.18x	3.89x	3.8x	3.74x
EV / Revenue	7.68x	4.24x	3.37x	3.4x	3.05x	3.6x	3.44x	3.32x
EV / EBITDA	33.1x	17.8x	16.8x	18.2x	17.4x	22.6x	20.8x	20x
EV / EBIT	39.3x	22.7x	23.7x	26.4x	25.3x	32.2x	28.4x	27.1x
EV / FCF	41.9x	127x	24x	-	-	30.2x	28.7x	26.9x
FCF Yield	2.39%	0.79%	4.17%	-	-	3.31%	3.49%	3.72%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	140.6	-	-21.82	-65.36	27.85	8.32	8.51	8.45
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,923	2,802	2,671	2,566	2,583	2,573	2,633	2,682
EBITDA ¹	677.5	667.9	535.9	479.5	453.2	410.3	435.1	446.5
EBIT ¹	571.2	524	378.9	331.3	311.6	287.5	318.4	328.8
Net income ¹	4,246	-3,628	-637.3	-1,844	759.9	224.8	229.7	228.3
Net Debt ¹	-	-592.5	-407.6	-452.1	-337.7	-749	-965.4	-1,107
Reference price ²	755.57	420.49	322.89	328.51	302.99	376.97	376.97	376.97
Nbr of stocks (in thousands)	29,918	29,824	29,145	27,997	26,975	26,738	-	-
Announcement Date	10/2/22	16/2/23	15/2/24	13/2/25	12/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIO-RAD LABORATORIES, INC.	45.31x	3.6x	22.59x	-.--%	10.02B
ABBOTT LABORATORIES	30.19x	4.1x	15.74x	2.44%	182B
MEDTRONIC PLC	19.44x	3.55x	12.69x	3.09%	118B
CENCORA, INC.	17.7x	0.21x	12.92x	0.74%	61.7B
HOYA CORPORATION	28.46x	7x	18.03x	1.4%	50.55B
BECTON, DICKINSON AND COMPANY	34.65x	3.36x	11.52x	2.18%	48.98B
DEXCOM, INC.	33.62x	5.91x	18.54x	-.--%	31.65B
MEDLINE INC.	43.96x	1.28x	11.86x	0.21%	29.87B
WEST PHARMACEUTICAL SERVICES, INC.	39.29x	6.88x	24.67x	0.27%	23.71B
TERUMO CORPORATION	16.9x	2.69x	9.55x	1.64%	21.78B
Average	30.95x	3.86x	15.81x	1.2%	57.79B
Weighted average by Cap.	27.93x	3.77x	14.87x	1.87%